Skip to main content

TENOFOVIR DISOPROXIL FUMARATE

NDC 62135-466 · Chartwell RX, LLC.

Generic nameTENOFOVIR DISOPROXIL FUMARATE Tablets
Dosage formTABLET, FILM COATED
RouteORAL
Active ingredient(s)TENOFOVIR DISOPROXIL FUMARATE
Strength300 mg/1
Pharmacologic classHepatitis B Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC], Nucleoside Reverse Transcriptase Inhibitors [MoA], Nucleosides [CS]
Marketing categoryANDA

Packages

62135-466-30 — 30 TABLET, FILM COATED in 1 BOTTLE (62135-466-30)

Related Codes

Same active ingredient

FDA lists these products with the same active ingredient.

61958-0403 — TENOFOVIR DISOPROXIL FUMARATE, 61958-0404 — TENOFOVIR DISOPROXIL FUMARATE, 61958-0405 — TENOFOVIR DISOPROXIL FUMARATE, 61958-0406 — TENOFOVIR DISOPROXIL FUMARATE, 61958-0701 — emtricitabine and tenofovir disoproxil fumarate, 61958-0703 — emtricitabine and tenofovir disoproxil fumarate, 61958-0704 — emtricitabine and tenofovir disoproxil fumarate, 61958-0705 — emtricitabine and tenofovir disoproxil fumarate, 61958-1101 — emtricitabine, rilpivirine hydrochloride, and tenofovir disoproxil fumarate, 61958-1201 — elvitegravir, cobicistat, emtricitabine, and tenofovir disoproxil fumarate, 63629-9729 — Tenofovir Disoproxil Fumarate, 64380-714 — tenofovir disoproxil fumarate, 64380-719 — EMTRICITABINE and TENOFOVIR Disoproxil Fumarate, 65862-354 — Emtricitabine and Tenofovir Disoproxil Fumarate, 65862-421 — Tenofovir Disoproxil Fumarate, 65862-497 — Efavirenz, Emtricitabine and Tenofovir Disoproxil Fumarate, 65862-818 — Tenofovir Disoproxil Fumarate, 65862-819 — Tenofovir Disoproxil Fumarate, 65862-820 — Tenofovir Disoproxil Fumarate, 67296-2198 — Emtricitabine and tenofovir disoproxil fumarate, +69 more

Read from: FDA National Drug Code Directory, product.txt and package.txt (accessdata.fda.gov/cder/ndctext.zip) — Snapshot retrieved 2026-08-24, loaded 2026-08-24; CMS Medicare Part B Drug Average Sales Price (ASP) Pricing Files (cms.gov/medicare/payment/part-b-drugs/asp-pricing-files) -- the NDC-HCPCS crosswalk and Part B payment limit files — 2026 Q3 (July 2026 release). All data sources · How to read the labels